ORGANON & CO (OGN) Stock Fundamental Analysis

NYSE:OGN • US68622V1061

7.19 USD
-0.1 (-1.37%)
At close: Mar 2, 2026
7.3 USD
+0.11 (+1.53%)
After Hours: 3/2/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall OGN gets a fundamental rating of 5 out of 10. We evaluated OGN against 193 industry peers in the Pharmaceuticals industry. OGN scores excellent on profitability, but there are concerns on its financial health. OGN is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • OGN had positive earnings in the past year.
  • OGN had a positive operating cash flow in the past year.
  • Each year in the past 5 years OGN has been profitable.
  • Each year in the past 5 years OGN had a positive operating cash flow.
OGN Yearly Net Income VS EBIT VS OCF VS FCFOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.45%, OGN belongs to the top of the industry, outperforming 81.87% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 24.87%, OGN belongs to the top of the industry, outperforming 92.75% of the companies in the same industry.
  • OGN's Return On Invested Capital of 10.22% is amongst the best of the industry. OGN outperforms 89.64% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for OGN is below the industry average of 12.91%.
Industry RankSector Rank
ROA 1.45%
ROE 24.87%
ROIC 10.22%
ROA(3y)5.51%
ROA(5y)7.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.88%
ROIC(5y)13.46%
OGN Yearly ROA, ROE, ROICOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • OGN has a better Profit Margin (3.01%) than 81.35% of its industry peers.
  • OGN's Profit Margin has declined in the last couple of years.
  • OGN's Operating Margin of 21.81% is amongst the best of the industry. OGN outperforms 89.64% of its industry peers.
  • In the last couple of years the Operating Margin of OGN has declined.
  • Looking at the Gross Margin, with a value of 53.30%, OGN is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
  • In the last couple of years the Gross Margin of OGN has declined.
Industry RankSector Rank
OM 21.81%
PM (TTM) 3.01%
GM 53.3%
OM growth 3Y-8.43%
OM growth 5Y-13.12%
PM growth 3Y-41.27%
PM growth 5Y-38.09%
GM growth 3Y-5.75%
GM growth 5Y-4.63%
OGN Yearly Profit, Operating, Gross MarginsOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so OGN is still creating some value.
  • The number of shares outstanding for OGN has been increased compared to 1 year ago.
  • OGN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, OGN has an improved debt to assets ratio.
OGN Yearly Shares OutstandingOGN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
OGN Yearly Total Debt VS Total AssetsOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 1.23, we must say that OGN is in the distress zone and has some risk of bankruptcy.
  • OGN has a Altman-Z score (1.23) which is comparable to the rest of the industry.
  • OGN has a debt to FCF ratio of 22.51. This is a negative value and a sign of low solvency as OGN would need 22.51 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 22.51, OGN is doing good in the industry, outperforming 76.17% of the companies in the same industry.
  • A Debt/Equity ratio of 11.47 is on the high side and indicates that OGN has dependencies on debt financing.
  • The Debt to Equity ratio of OGN (11.47) is worse than 81.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.47
Debt/FCF 22.51
Altman-Z 1.23
ROIC/WACC1.65
WACC6.18%
OGN Yearly LT Debt VS Equity VS FCFOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • OGN has a Current Ratio of 1.82. This is a normal value and indicates that OGN is financially healthy and should not expect problems in meeting its short term obligations.
  • OGN has a worse Current ratio (1.82) than 63.73% of its industry peers.
  • OGN has a Quick Ratio of 1.23. This is a normal value and indicates that OGN is financially healthy and should not expect problems in meeting its short term obligations.
  • OGN has a Quick ratio of 1.23. This is in the lower half of the industry: OGN underperforms 70.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.23
OGN Yearly Current Assets VS Current LiabilitesOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for OGN have decreased strongly by -10.95% in the last year.
  • The earnings per share for OGN have been decreasing by -39.06% on average. This is quite bad
  • OGN shows a decrease in Revenue. In the last year, the revenue decreased by -2.92%.
  • OGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.99% yearly.
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5Y-39.06%
EPS Q2Q%-30%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y0.23%
Revenue growth 5Y-0.99%
Sales Q2Q%-5.34%

3.2 Future

  • OGN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.74% yearly.
  • The Revenue is expected to grow by 0.43% on average over the next years.
EPS Next Y5.85%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
EPS Next 5Y1.74%
Revenue Next Year-1.78%
Revenue Next 2Y-0.08%
Revenue Next 3Y0.62%
Revenue Next 5Y0.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGN Yearly Revenue VS EstimatesOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
OGN Yearly EPS VS EstimatesOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 1.96, which indicates a rather cheap valuation of OGN.
  • 98.96% of the companies in the same industry are more expensive than OGN, based on the Price/Earnings ratio.
  • OGN is valuated cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 1.86, which indicates a rather cheap valuation of OGN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 98.45% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. OGN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.96
Fwd PE 1.86
OGN Price Earnings VS Forward Price EarningsOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • OGN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OGN is cheaper than 96.89% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, OGN is valued cheaper than 96.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.87
EV/EBITDA 5.8
OGN Per share dataOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of OGN may justify a higher PE ratio.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y5.13%
EPS Next 3Y5.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.11%, OGN has a reasonable but not impressive dividend return.
  • OGN's Dividend Yield is rather good when compared to the industry average which is at 0.67. OGN pays more dividend than 90.67% of the companies in the same industry.
  • OGN's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

  • OGN has been paying a dividend for over 5 years, so it has already some track record.
  • OGN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
OGN Yearly Dividends per shareOGN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 47.06% of the earnings are spent on dividend by OGN. This is a bit on the high side, but may be sustainable.
DP47.06%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
OGN Yearly Income VS Free CF VS DividendOGN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
OGN Dividend Payout.OGN Dividend Payout, showing the Payout Ratio.OGN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGANON & CO

NYSE:OGN (3/2/2026, 8:04:00 PM)

After market: 7.3 +0.11 (+1.53%)

7.19

-0.1 (-1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners79.58%
Inst Owner Change-1.31%
Ins Owners0.36%
Ins Owner Change1.29%
Market Cap1.87B
Revenue(TTM)6.22B
Net Income(TTM)187.00M
Analysts48.75
Price Target9.18 (27.68%)
Short Float %5.56%
Short Ratio2.59
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP47.06%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.71%
Min EPS beat(2)-14.22%
Max EPS beat(2)6.8%
EPS beat(4)3
Avg EPS beat(4)2.37%
Min EPS beat(4)-14.22%
Max EPS beat(4)12.44%
EPS beat(8)6
Avg EPS beat(8)4.4%
EPS beat(12)8
Avg EPS beat(12)3.56%
EPS beat(16)11
Avg EPS beat(16)5.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)0.69%
Revenue beat(4)2
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)-0.29%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)9
Avg Revenue beat(16)-0.15%
PT rev (1m)-3.82%
PT rev (3m)-6.9%
EPS NQ rev (1m)-17.39%
EPS NQ rev (3m)-16.83%
EPS NY rev (1m)-3.04%
EPS NY rev (3m)-5.07%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)-0.93%
Revenue NY rev (3m)-3.39%
Valuation
Industry RankSector Rank
PE 1.96
Fwd PE 1.86
P/S 0.3
P/FCF 4.87
P/OCF 2.67
P/B 2.49
P/tB N/A
EV/EBITDA 5.8
EPS(TTM)3.66
EY50.9%
EPS(NY)3.87
Fwd EY53.88%
FCF(TTM)1.48
FCFY20.54%
OCF(TTM)2.69
OCFY37.45%
SpS23.91
BVpS2.89
TBVpS-17.43
PEG (NY)0.34
PEG (5Y)N/A
Graham Number15.43
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 24.87%
ROCE 12.94%
ROIC 10.22%
ROICexc 10.82%
ROICexgc 23.19%
OM 21.81%
PM (TTM) 3.01%
GM 53.3%
FCFM 6.18%
ROA(3y)5.51%
ROA(5y)7.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.88%
ROIC(5y)13.46%
ROICexc(3y)11.64%
ROICexc(5y)14.58%
ROICexgc(3y)28.78%
ROICexgc(5y)42.53%
ROCE(3y)13.77%
ROCE(5y)17.04%
ROICexgc growth 3Y-25.36%
ROICexgc growth 5Y-17.91%
ROICexc growth 3Y-15.47%
ROICexc growth 5Y-16.06%
OM growth 3Y-8.43%
OM growth 5Y-13.12%
PM growth 3Y-41.27%
PM growth 5Y-38.09%
GM growth 3Y-5.75%
GM growth 5Y-4.63%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 11.47
Debt/FCF 22.51
Debt/EBITDA 5.03
Cap/Depr 87.53%
Cap/Sales 5.08%
Interest Coverage 2.93
Cash Conversion 40.77%
Profit Quality 205.35%
Current Ratio 1.82
Quick Ratio 1.23
Altman-Z 1.23
F-Score5
WACC6.18%
ROIC/WACC1.65
Cap/Depr(3y)108.28%
Cap/Depr(5y)123.91%
Cap/Sales(3y)4.91%
Cap/Sales(5y)4.87%
Profit Quality(3y)108.67%
Profit Quality(5y)109.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5Y-39.06%
EPS Q2Q%-30%
EPS Next Y5.85%
EPS Next 2Y5.13%
EPS Next 3Y5.79%
EPS Next 5Y1.74%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y0.23%
Revenue growth 5Y-0.99%
Sales Q2Q%-5.34%
Revenue Next Year-1.78%
Revenue Next 2Y-0.08%
Revenue Next 3Y0.62%
Revenue Next 5Y0.43%
EBIT growth 1Y-7.44%
EBIT growth 3Y-8.23%
EBIT growth 5Y-13.98%
EBIT Next Year11.97%
EBIT Next 3Y6.45%
EBIT Next 5Y5.4%
FCF growth 1Y-34.69%
FCF growth 3Y-11.55%
FCF growth 5Y-27.61%
OCF growth 1Y-25.45%
OCF growth 3Y-6.56%
OCF growth 5Y-20.37%

ORGANON & CO / OGN FAQ

Can you provide the ChartMill fundamental rating for ORGANON & CO?

ChartMill assigns a fundamental rating of 5 / 10 to OGN.


What is the valuation status of ORGANON & CO (OGN) stock?

ChartMill assigns a valuation rating of 9 / 10 to ORGANON & CO (OGN). This can be considered as Undervalued.


What is the profitability of OGN stock?

ORGANON & CO (OGN) has a profitability rating of 7 / 10.


What is the valuation of ORGANON & CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ORGANON & CO (OGN) is 1.96 and the Price/Book (PB) ratio is 2.49.


What is the expected EPS growth for ORGANON & CO (OGN) stock?

The Earnings per Share (EPS) of ORGANON & CO (OGN) is expected to grow by 5.85% in the next year.